APA

Feigal E. G., Tsokas K., Zhang J., Cromer M. V., Whittlesey K. J. & Werner M. J. (20130130). Perspective: communications with the Food and Drug Administration on the development pathway for a cell-based therapy: why, what, when, and how?. : Stem cells translational medicine.

Chicago

Feigal Ellen G, Tsokas Katherine, Zhang Jiwen, Cromer Marc V, Whittlesey Kevin J and Werner Michael J. 20130130. Perspective: communications with the Food and Drug Administration on the development pathway for a cell-based therapy: why, what, when, and how?. : Stem cells translational medicine.

Harvard

Feigal E. G., Tsokas K., Zhang J., Cromer M. V., Whittlesey K. J. and Werner M. J. (20130130). Perspective: communications with the Food and Drug Administration on the development pathway for a cell-based therapy: why, what, when, and how?. : Stem cells translational medicine.

MLA

Feigal Ellen G, Tsokas Katherine, Zhang Jiwen, Cromer Marc V, Whittlesey Kevin J and Werner Michael J. Perspective: communications with the Food and Drug Administration on the development pathway for a cell-based therapy: why, what, when, and how?. : Stem cells translational medicine. 20130130.